Literature DB >> 17381477

Scottish GPs use of homeopathy.

Robert Leckridge.   

Abstract

Mesh：

Year:  2007        PMID： 17381477      PMCID： PMC2000641          DOI： 10.1111/j.1365-2125.2007.02877.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Clinical outcomes research: contributions to the evidence base for homeopathy.

Authors:  Robert T Mathie
Journal:  Homeopathy       Date:  2003-01       Impact factor: 1.444

Review 2.  All evidence is equal, but some evidence is more equal than others: can logic prevail over emotion in the homeopathy debate?

Authors:  Iris R Bell
Journal:  J Altern Complement Med       Date:  2005-10       Impact factor: 2.579

3.  Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy.

Authors:  Aijing Shang; Karin Huwiler-Müntener; Linda Nartey; Peter Jüni; Stephan Dörig; Jonathan A C Sterne; Daniel Pewsner; Matthias Egger
Journal:  Lancet       Date:  2005 Aug 27-Sep 2       Impact factor: 79.321

4.  Homoeopathic and herbal prescribing in general practice in Scotland.

Authors:  Sarah Ross; Colin R Simpson; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2006-06-23       Impact factor: 4.335

5.  Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials.

Authors:  K Linde; N Clausius; G Ramirez; D Melchart; F Eitel; L V Hedges; W B Jonas
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

6.  Histamine dilutions modulate basophil activation.

Authors:  P Belon; J Cumps; M Ennis; P F Mannaioni; M Roberfroid; J Sainte-Laudy; F A C Wiegant
Journal:  Inflamm Res       Date:  2004-04-21       Impact factor: 4.575

7.  Homeopathy and The Lancet.

Authors:  Peter Fisher
Journal:  Evid Based Complement Alternat Med       Date:  2006-03       Impact factor: 2.629
  7 in total
  1 in total

1.  Should we tolerate tolerability as an objective in early drug development?

Authors:  A Cohen
Journal:  Br J Clin Pharmacol       Date:  2007-09       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.